personal scheduler Hamburg 2013 - Main Site Press Release 2013 Call for Abstracts General Information Programme Overview Letter from the President Keynote Lectures Main Sessions NEW - Free Paper Session Instructional Courses World Retina Day Retinal Detachment Course Uveitis Course Other Symposia Surgical Skills Training Courses
hamburg banner

Early macular microperimetry profile after intravitreal bevacizumab for treatment of macular odema associated with RVO

Session Details

Session Title: Vascular Diseases III

Session Date/Time: Sunday 29/09/2013 | 08:00-10:00

Paper Time: 09:04

Venue: Hall 3 (Level 0)

First Author: S.Hemachandran SAUDI ARABIA

Co Author(s):    A. Al Kharashi   A. Al Asrar           

Abstract Details


To evaluate the early macular function changes using microperimetry after intravitreal injection of bevacizumab for the treatment of macular odema associated with Retinal Vein Occlusion.


Vitreo-Retinal Division of the Department of Ophthalmology, King Abdul Aziz University Hospital, King Saud University, Riyadh, Kingdom of Saudi Arabia.


In this interventional case series 96 eyes of 96 patients with macular odema associated with retinal vein occlusion and treated with intravitreal injection of Bevacizumab. Macular microperimetry was obtained at presentation before treatment and at one week post treatment.


Wholesome improvement in macular function - Sensitivity, fixation and Stability was detected immediately after treatment with intravitral injection of Bevacizumab as measured by Microperimetry.


Intravitral Injection of Bevacizumab given early after the onset of Retinal Vein Occlusion results in improvement and better Macular function and therby results in significant decrease in Macular odema and corresponding increase in Visual acuity.

Back to Freepaper Session
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy